Literature DB >> 29610273

Subcellular compartmentalization of proximal Gαq-receptor signaling produces unique hypertrophic phenotypes in adult cardiac myocytes.

Erika F Dahl1, Steven C Wu2, Chastity L Healy2, Brian A Harsch3, Gregory C Shearer3, Timothy D O'Connell4.   

Abstract

G protein-coupled receptors that signal through Gαq (Gq receptors), such as α1-adrenergic receptors (α1-ARs) or angiotensin receptors, share a common proximal signaling pathway that activates phospholipase Cβ1 (PLCβ1), which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) to produce inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. Despite these common proximal signaling mechanisms, Gq receptors produce distinct physiological responses, yet the mechanistic basis for this remains unclear. In the heart, Gq receptors are thought to induce myocyte hypertrophy through a mechanism termed excitation-transcription coupling, which provides a mechanistic basis for compartmentalization of calcium required for contraction versus IP3-dependent intranuclear calcium required for hypertrophy. Here, we identified subcellular compartmentalization of Gq-receptor signaling as a mechanistic basis for unique Gq receptor-induced hypertrophic phenotypes in cardiac myocytes. We show that α1-ARs co-localize with PLCβ1 and PIP2 at the nuclear membrane. Further, nuclear α1-ARs induced intranuclear PLCβ1 activity, leading to histone deacetylase 5 (HDAC5) export and a robust transcriptional response (i.e. significant up- or down-regulation of 806 genes). Conversely, we found that angiotensin receptors localize to the sarcolemma and induce sarcolemmal PLCβ1 activity, but fail to promote HDAC5 nuclear export, while producing a transcriptional response that is mostly a subset of α1-AR-induced transcription. In summary, these results link Gq-receptor compartmentalization in cardiac myocytes to unique hypertrophic transcription. They suggest a new model of excitation-transcription coupling in adult cardiac myocytes that accounts for differential Gq-receptor localization and better explains distinct physiological functions of Gq receptors.
© 2018 Dahl et al.

Entities:  

Keywords:  G protein signaling; G protein-coupled receptor (GPCR); adrenergic receptor; angiotensin II; angiotensin receptor; cardiac hypertrophy; cell compartmentalization; cell signaling; intracellular compartmentalization; myocardial biology; signaling mechanism

Mesh:

Substances:

Year:  2018        PMID: 29610273      PMCID: PMC5995527          DOI: 10.1074/jbc.RA118.002283

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Gq signaling in cardiac adaptation and maladaptation.

Authors:  G W Dorn; J H Brown
Journal:  Trends Cardiovasc Med       Date:  1999 Jan-Feb       Impact factor: 6.677

Review 2.  Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.

Authors:  Steven G Chrysant
Journal:  Clin Ther       Date:  2008       Impact factor: 3.393

3.  Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy.

Authors:  Lianghui Zhang; Sundeep Malik; Jinjiang Pang; Huan Wang; Keigan M Park; David I Yule; Burns C Blaxall; Alan V Smrcka
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

4.  Spatiotemporally distinct protein kinase D activation in adult cardiomyocytes in response to phenylephrine and endothelin.

Authors:  Julie Bossuyt; Chia-Wei Chang; Kathryn Helmstadter; Maya T Kunkel; Alexandra C Newton; Kenneth S Campbell; Jody L Martin; Sven Bossuyt; Seth L Robia; Donald M Bers
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

5.  Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.

Authors:  Artavazd Tadevosyan; Ange Maguy; Louis R Villeneuve; Judith Babin; Arnaud Bonnefoy; Bruce G Allen; Stanley Nattel
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

6.  Low level of sarcolemmal phosphatidylinositol 4,5-bisphosphate in cardiomyopathic hamster (UM-X7.1) heart.

Authors:  A Ziegelhoffer; P S Tappia; N Mesaeli; N Sahi; N S Dhalla; V Panagia
Journal:  Cardiovasc Res       Date:  2001-01       Impact factor: 10.787

7.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  A mouse model of angiotensin II slow pressor response: role of oxidative stress.

Authors:  Noritaka Kawada; Enyu Imai; Alexsander Karber; William J Welch; Christopher S Wilcox
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

9.  Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

Authors:  Julian C Braz; Orlando F Bueno; Qiangrong Liang; Benjamin J Wilkins; Yan-Shan Dai; Stephanie Parsons; Joseph Braunwart; Betty J Glascock; Raisa Klevitsky; Thomas F Kimball; Timothy E Hewett; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 10.  cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies.

Authors:  Manuela Zaccolo
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

View more
  8 in total

1.  Coupling to Gq Signaling Is Required for Cardioprotection by an Alpha-1A-Adrenergic Receptor Agonist.

Authors:  Bat-Erdene Myagmar; Taylor Ismaili; Philip M Swigart; Anaha Raghunathan; Anthony J Baker; Sunil Sahdeo; Jonathan M Blevitt; Marcos E Milla; Paul C Simpson
Journal:  Circ Res       Date:  2019-08-20       Impact factor: 17.367

Review 2.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

3.  Adhesive thermosensitive gels for local delivery of viral vectors.

Authors:  Jeanette M Caronia; Daniel W Sorensen; Hope M Leslie; Jop H van Berlo; Samira M Azarin
Journal:  Biotechnol Bioeng       Date:  2019-05-20       Impact factor: 4.530

4.  Norepinephrine activates β1 -adrenergic receptors at the inner nuclear membrane in astrocytes.

Authors:  Kelsey C Benton; Daniel S Wheeler; Beliz Kurtoglu; Mahshid Bagher Zadeh Ansari; Daniel P Cibich; Dante A Gonzalez; Matthew R Herbst; Saema Khursheed; Rachel C Knorr; Doug Lobner; Jenree G Maglasang; Kayla E Rohr; Analisa Taylor; Robert C Twining; Paul J Witt; Paul J Gasser
Journal:  Glia       Date:  2022-05-19       Impact factor: 8.073

Review 5.  Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases.

Authors:  Jiandong Zhang; Paul C Simpson; Brian C Jensen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-04       Impact factor: 4.733

6.  Golgi localized β1-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLCε to regulate cardiac hypertrophy.

Authors:  Craig A Nash; Wenhui Wei; Roshanak Irannejad; Alan V Smrcka
Journal:  Elife       Date:  2019-08-21       Impact factor: 8.140

7.  Concentrations of Mg, Ca, Fe, Cu, Zn, P and anthropometric and biochemical parameters in adults with chronic heart failure.

Authors:  Iwona Gorący; Ewa Rębacz-Maron; Jan Korbecki; Jarosław Gorący
Journal:  PeerJ       Date:  2021-11-01       Impact factor: 2.984

8.  NF-kB signaling in cardiomyocytes is inhibited by sevoflurane and promoted by propofol.

Authors:  Keiko Oda-Kawashima; Anna S Sedukhina; Naoki Okamoto; Mariya Lytvyn; Kimino Minagawa; Teppei Iwata; Toshio Kumai; Eri Sato; Eiichi Inada; Ayako Yamaura; Miki Sakamoto; Marta Roche-Molina; Juan A Bernal; Ko Sato
Journal:  FEBS Open Bio       Date:  2020-01-15       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.